Results 141 to 150 of about 20,923 (159)

Empagliflozin

Reactions Weekly, 2016
openaire   +1 more source

Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial

Circulation, 2021
Faiez Zannad, Wolfram Doehner, Javed Butler   +2 more
exaly  

Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure

Circulation, 2023
Faiez Zannad, Javed Butler, Cordula Zeller   +2 more
exaly  

Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure

Circulation: Heart Failure, 2021

exaly  

Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

Circulation, 2022
Faiez Zannad, Javed Butler, Vijay K Chopra   +2 more
exaly  

Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial

European Heart Journal, 2021
Nadia Giannetti, Faiez Zannad, Javed Butler   +2 more
exaly  

Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care

Circulation, 2019
Anouk Déruaz-Luyet, Kimberly G Brodovicz, Martin Kulldorff   +2 more
exaly  

Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes

Diabetes Care, 2015
Sanjay R Patel
exaly  

Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin

Diabetes Care, 2015
Ralph DeFronzo, Sanjay R Patel
exaly  

Initial Combination of Empagliflozin and Metformin in Patients With Type 2 Diabetes

Diabetes Care, 2016
Julio Rosenstock, Hans J Woerle, Thomas Meinicke   +2 more
exaly